Paul Goode, GlucoTrack’s CEO, wants to “keep pushing the boundaries” by giving people living with diabetes an alternative to standard glucose monitoring technology. While still early in development, t
One of the hallmarks of the digital health market is how fast trends can develop. Although a movement toward wearable devices has only just begun to emerge, a newer trend of using implantable sensors
IN VITRO DIAGNOSTICS bioTheranostics Inc. Late round brings $32mm to bioTheranostics ; company becomes independent Molecular diagnostics firm bioTheranostics Inc. raised $32mm in a late-stage f